.png)
Determine Permeability and more
You can determine small molecule and micro/nano-particle toxicity and permeability across barrier
Highest Throughput
Depending on the assay, it is possbile to have 384 individual microfluidic assays running on a single 96-well plate footprint
Human Mimetic models
Mimic human and animal biological barriers such as Blood-Brain-Barrier, Vasculature and Lung
No pumps
Our model can provide bi-directional microfluidics without the use of external pumps. This makes our platform extremely efficient and easy to handle.
The Management Team
Prateek Singh
CEO & Founder
Prateek established Finnadvance in 2018, and got EU Horizon 2020 funding as a one-person company. He has 14 years of experience in bioengineering and holds Btech in Biotechnology and MSc in Biochemistry and Protein science.
Jari Moilanen
COO
Jari handles the daily operations at Finnadvance. He is experienced in operations management, B2B sales, procurement and industry consulting. Jari holds MSc in marketing and management from the University of Helsinki, Finland.
Tuan Nguyen
CTO
Tuan runs our chip production and development laboratory, and is an experienced industrial bioengineer and microtechnology expert. Tuan holds MSc in biomedical engineering from the International University of Ho Chi Minh City, Vietnam.
Team
Finnadvance has grown to a size of total 22 employees. We will update the team information shortly.
Check back soon!
How Finnadvance Can Help You?
Scale Down Animal Tests
More Accurate Biomimetic for Target Biology
26% Cost Reduction for Drug Development
Succeed in Clinical Trials with Better Pre-Clinical Data
Multiple Organ-On-Chip Designs
Finnadvance
Investment
News
Here you find the current developments of our company.
Ready to Accelerate your Drug Development?
Get in contact with our professional team to know more about our products and services.
We also offer collaboration opportunities to Academic Research Groups.
We will help you with any questions you might have.